Salesforce Friends ...
Health Care: Drugs
Facet Biotech Corporation (FACT: NASDAQ)
$27.01 0.00 | 0.00%
04/21/10 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| FACT | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 24.60 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 69.98 | 195.84 | 1567.28 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 152.40 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for FACT:
| EBITDA | -99.00 |
| REVENUE | 46.10M |
Average Earnings Estimates
| Qtr (03/10) | Qtr (06/10) | FY (12/10) | FY (12/11) | |
|---|---|---|---|---|
| Average Estimate | $-0.69 | $-0.14 | $-3.65 | $-4.83 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $-0.68 | $-0.05 | $-3.34 | $-4.41 |
| Low Estimate | $-0.71 | $-0.22 | $-3.96 | $-5.25 |
| Prior Year | $-1.22 | $-1.71 | $-5.09 | $-3.65 |
| Growth Rate (Year over Year) | 43.03% | 92.11% | 28.29% | -32.33% |
Portfolios with FACT
- Portfolio NameUser Type
- UserFree Picks
- ContributorBarron's Activist Stocks 3-...
- ContributorBarron's Activist Stocks 2-...
- ContributorBarron's Activist Stocks 12...
- UserLeftovers
- ContributorBarron's Activist Stocks 10...
- UserTop Line Portfolio
- ContributorBarron's Activist Stocks 9-...
- ContributorBarron's Activist Stocks 5-...
- UserLast Day of the JPMorgan He...
Latest FACT Headlines from TheStreet
- Stock Wrap: The Real Story, March 12
03.12.10 | 04:03 pm - Nasdaq Leads Market Higher 03.10.10 | 06:03 pm
- Citigroup: Wednesday's Headlines 03.10.10 | 08:03 am
- Facet Biotech Stock Soars on Abbott Bid 03.09.10 | 06:03 pm
- Director William Furman Buys $1.5M Worth of Schnitzer Steel 02.10.10 | 09:02 am
- President Sergey Brin Sells $44.3M Worth of Google 02.05.10 | 10:02 am
- President James Truchard Sells $7.7M National Instruments 02.01.10 | 09:02 am
- Facet Shareholders Reject Biogen Takeover Bid 12.17.09 | 11:12 am
- Biogen Threatens Proxy Fight In Facet Bid 12.15.09 | 04:12 pm
- Facet Board Recommends Rejection Of Biogen Bid 12.10.09 | 10:12 am
Press Releases for FACT
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Facet Biotech Corporation By Abbott Laboratories - Business Wire 03.12.10 | 11:03 am
- Kendall Law Group Investigates Facet Biotech Corporation Merger For Shareholders - Business Wire 03.10.10 | 12:03 pm
- Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of Facet Biotech Corporation - Business Wire 03.10.10 | 08:03 am
- Levi & Korsinsky, LLP Investigates Possible Breach Of Fiduciary Duty By The Board Of Facet Biotech Corporation - FACT - Business Wire 03.09.10 | 09:03 pm
- Abbott Enhances Pharmaceutical Pipeline With Acquisition Of Facet Biotech - PR Newswire 03.09.10 | 04:03 pm
- Jennerex Appoints Dr. Hoyoung Huh To Its Board Of Directors - PR Newswire 01.11.10 | 09:01 am
Partner Headlines for FACT
- Four Biotech Stocks Investing Guru Seth Klarman Owns - Seeking Alpha 01.21.11 | 04:01 pm
- Seth Klarman's Baupost Group: New Positions in ADC Telecommunications and Solar Capital - Seeking Alpha 05.17.10 | 05:05 pm
- Seth Klarman's Baupost Group Exits Facet Biotech - SeekingAlpha.com 04.22.10 | 10:04 am
- Hedge Fund Baupost Group Updates Facet, ViaSat and Theravance Holdings - SeekingAlpha.com 04.13.10 | 12:04 am
- Abbott a Step Closer to FACT - Analyst Blog - Zacks 04.09.10 | 03:04 pm
- Abbott Completes Starlims Buyout - Analyst Blog - Zacks 03.23.10 | 06:03 pm
- Trubion Loss Wider Than Expected - Analyst Blog - Zacks 03.22.10 | 04:03 pm
- Facet Biotech (FACT) Wins Big in Abbott, Biogen Battle - ONN.TV 03.10.10 | 07:03 pm
- Company News for March 10, 2010 - Corporate Summary - Zacks 03.10.10 | 10:03 am
- UPDATE 3-Abbott to buy Facet for $27/shr, topping Biogen bid - Reuters 03.09.10 | 07:03 pm
